Push release MHRA approves GLP –one receptor agonist semaglutide to lessen risk of significant heart complications in obese or overweight Grown ups Semaglutide is the main weight-loss drug authorised in the UK for a preventative therapy for those with established cardiovascular diseaseBefore utilizing Wegovy®, convey to your healthcare service p